Bacteremia caused by staphylococci with inducible vancomycin heteroresistance

Clinical Infectious Diseases

Volumn 29, Issue 4, 1999, Pages 760-767

  Wong, Samson S Y ^a   Ho, P L ^a   Woo, Patrick C Y ^a   Yuen, K Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; GLYCOPEPTIDE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; HOSPITAL ADMISSION; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS;

EID: 0033509736     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520429     Document Type: Article

References (22)

1. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-36.
2. Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin United States, 1907. MMWR Morb Mortal Wkly Rep 1997:46:813-5.
3. Ploy MC, Grélaud C, Marlin C, de Lumley L, Dennis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital [letter]. Lancet 1998;351:1212.
4. Hiramatsu K, Aritaka N, Hanaki H, et al. Disscmination in Japanese hospitals of strains of Staphylococcus aureus heterogeneonsly resistant to vancomycin. Lancet 1997:350:1670-3.
5. Schwalbe RS, Ritz WJ, Verma PR, Barranco EA, Gilligan PTI. Selection For vancomycin resistance in clinical isolates of Staphylococcus hae-molyticus. J Infect Dis 1990;161:45-51.
6. Yuen KY, Woo PCY, Hui CH, et al. Unique risk factors for bacteremia in allogenic bone marrow transplant recipients before and after engraftment. Bone Marrow Transplant 1998;21:1137-43.
7. Kloos WE, Bannerman TL. Staphylococcus and Micrococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington DC: American Society for Microbiology Press, 1995:282-98.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: eighth informational supplement. NCCLS document M 100-S8. Villanova, PA: National Committee for Clinical Laboratory Standards, 1998.
9. National Committee for Clinical Laboratory Standards, Performance standards for antimicrobial disk susceptibility tests: approved standard. 6th ed. NCCLS document M2-A6. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997.
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: approved standard, 4th ed, NCCLS document M7-A4. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997.
11. Crowe MJ, Cooke EM. Review of case definition for nosocomial infection-towards a consensus. J Hosp Infect 1998;39:3-11.
12. McCabe WW, Jackson GG. Gram negative bacteremia I. Etiology and ecology. Arch Intern Med 1962;110:847-55.
13. Tenover F, Lancaster M, Hill BC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998;36:1020-7.
14. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis in clinical implications. Clin Microbiol Rev 1997;10:781-791.
15. Chambers HF. Methicillin-resistant staphylococci. Clin Microbiol Rev 1988;1:173-86.
16. Sieradzki K, Tomasz A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly resistant mutant of Staphylococcus aureus. J Bacteriol 1997;170:2557-66.
17. Moreira B, Boyle-Vavra S, de Jonge BLM, Daum RS. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. J Clin Microbiol 1997;41:1788-93.
18. Chambers HF, Hackbarth CJ. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogenous expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1987;31:1982-8.
19. Johnson AP, Uttley AHC, Woodford N, George RC. Resistance to vancomycin and telcoplanin: an emerging clinical problem. Clin Microbiol Rev 1990;3:280 91.
20. Hiramatsu K. Molecular evolution of MRSA. Microbiol Immunol 1995;39:1020-7.
21. Ho PL, Yuen KY, Yam WrY, Wong SSY, Luk WK. Changing susceptibilities of blood, urinary, and respiratory pathogens in Hong Kong. J Hosp Infect 1995;31:305-17.
22. Tacconelli E, Tumbarello M, Pittiruti M, et al. Central venous catheter related sepsis in a cohort of 366 hospitalised patients. Eur J Clin Microbiol Infect Dis 1997:16:203-9.